Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicenter Uncontrolled Trial of BAY43-9006 in Subjects With Metastatic Breast Cancer.

NCT00101400 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00101400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00101400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicenter Uncontrolled Trial of BAY43-9006 in Subjects With Metastatic Breast Cancer.
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2004
Completion date
January 31, 2008
Enrollment
54 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasms